NewGenIvf Group Limited
NIVF
$1.80
$0.052.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -132.24% | -119.41% | -28.85% | -28.85% | |
| Total Depreciation and Amortization | 7.72% | 122.46% | -83.69% | -83.69% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -704.14% | 86.56% | -33.33% | -33.33% | |
| Change in Net Operating Assets | -649.24% | -4,295.31% | 402.86% | 402.86% | |
| Cash from Operations | -2,610.12% | -4,804.20% | 347.22% | 347.22% | |
| Capital Expenditure | 84.57% | 23.85% | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | 178.29% | -5.53% | -- | -- | |
| Total Debt Issued | 1,110.69% | -175.42% | -- | -- | |
| Total Debt Repaid | 2,629.79% | -2,629.79% | 31.91% | 31.91% | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -226.47% | 580.94% | -580.93% | -580.93% | |
| Cash from Financing | 1,583.91% | 4,020.10% | -354.00% | -354.00% | |
| Foreign Exchange rate Adjustments | 130.03% | -652.44% | 633.51% | 633.51% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 1,594.71% | 64.18% | 161.04% | 161.04% | |